 |
Justin Petrone is the editor of GenomeWeb's BioArray News and covers the microarray and biochip sector of the genomics market. E-mail Justin Petrone or follow his GenomeWeb Twitter account at @BioArrayNews. |
'Provocative' Paper Sparks Debate on Relevance of Breast Cancer Gene Expression Signatures
September 04, 2012
'Provocative' Paper Sparks Debate on Relevance of Breast Cancer Gene Expression Signatures
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Axela Partners with OvaGene to Commercialize Ovarian Cancer PGx Test
August 21, 2012 / BioArray News - Almac Dx Plans to Debut Array-based Colorectal Cancer-Recurrence Test Next Year
November 15, 2011 / BioArray News - Agendia's Pipeline, Test Business Could Benefit From Companion-Dx Deal with AstraZeneca, NKI
May 24, 2011 / BioArray News - Agendia Moving to Larger Lab to Keep Pace with Growing MammaPrint Testing Volume
August 11, 2010 / Pharmacogenomics Reporter - New Releases
April 7, 2010 / Pharmacogenomics Reporter